Literature DB >> 28140328

Impact of Dietary Fibers on Nutrient Management and Detoxification Organs: Gut, Liver, and Kidneys.

Dorothy A Kieffer1,2,3, Roy J Martin1,2,3, Sean H Adams4,2,5,6.   

Abstract

Increased dietary fiber (DF) intake elicits a wide range of physiologic effects, not just locally in the gut, but systemically. DFs can greatly alter the gut milieu by affecting the gut microbiome, which in turn influences the gut barrier, gastrointestinal immune and endocrine responses, and nitrogen cycling and microbial metabolism. These gut-associated changes can then alter the physiology and biochemistry of the body's other main nutrient management and detoxification organs, the liver and kidneys. The molecular mechanisms by which DF alters the physiology of the gut, liver, and kidneys is likely through gut-localized events (i.e., bacterial nitrogen metabolism, microbe-microbe, and microbe-host cell interactions) coupled with specific factors that emanate from the gut in response to DF, which signal to or affect the physiology of the liver and kidneys. The latter may include microbe-derived xenometabolites, peptides, or bioactive food components made available by gut microbes, inflammation signals, and gut hormones. The intent of this review is to summarize how DF alters the gut milieu to specifically affect intestinal, liver, and kidney functions and to discuss the potential local and systemic signaling networks that are involved.
© 2016 American Society for Nutrition.

Entities:  

Keywords:  chronic kidney disease; fiber; microbiota; nonalcoholic fatty liver disease; xenobiotic

Mesh:

Year:  2016        PMID: 28140328      PMCID: PMC5105045          DOI: 10.3945/an.116.013219

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  144 in total

1.  Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.

Authors:  Paula Trumbo; Sandra Schlicker; Allison A Yates; Mary Poos
Journal:  J Am Diet Assoc       Date:  2002-11

2.  High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease.

Authors:  Vidya M Raj Krishnamurthy; Guo Wei; Bradley C Baird; Maureen Murtaugh; Michel B Chonchol; Kalani L Raphael; Tom Greene; Srinivasan Beddhu
Journal:  Kidney Int       Date:  2011-10-19       Impact factor: 10.612

Review 3.  Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.

Authors:  Jeffrey A Kraut; Ira Kurtz
Journal:  Am J Kidney Dis       Date:  2005-06       Impact factor: 8.860

4.  Glucagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro.

Authors:  Jasleen Jasleen; Stanley W Ashley; Naoshi Shimoda; Michael J Zinner; Edward E Whang
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

5.  Increasing digesta viscosity using carboxymethylcellulose in weaned piglets stimulates ileal goblet cell numbers and maturation.

Authors:  Christelle Piel; Lucile Montagne; Bernard Sève; Jean-Paul Lallès
Journal:  J Nutr       Date:  2005-01       Impact factor: 4.798

6.  Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.

Authors:  Luying Peng; Zhong-Rong Li; Robert S Green; Ian R Holzman; Jing Lin
Journal:  J Nutr       Date:  2009-07-22       Impact factor: 4.798

Review 7.  The core gut microbiome, energy balance and obesity.

Authors:  Peter J Turnbaugh; Jeffrey I Gordon
Journal:  J Physiol       Date:  2009-06-02       Impact factor: 5.182

Review 8.  Metabolomics in chronic kidney disease.

Authors:  Ying-Yong Zhao
Journal:  Clin Chim Acta       Date:  2013-04-06       Impact factor: 3.786

9.  Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients.

Authors:  M Rossi; D W Johnson; H Xu; J J Carrero; E Pascoe; C French; K L Campbell
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-04-09       Impact factor: 4.222

10.  Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals.

Authors:  Katri Korpela; Harry J Flint; Alexandra M Johnstone; Jenni Lappi; Kaisa Poutanen; Evelyne Dewulf; Nathalie Delzenne; Willem M de Vos; Anne Salonen
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

View more
  9 in total

Review 1.  Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation.

Authors:  Eirini Dimidi; Stephanos Christodoulides; S Mark Scott; Kevin Whelan
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

Review 2.  Therapeutic Benefits and Dietary Restrictions of Fiber Intake: A State of the Art Review.

Authors:  Corina-Bianca Ioniță-Mîndrican; Khaled Ziani; Magdalena Mititelu; Eliza Oprea; Sorinel Marius Neacșu; Elena Moroșan; Denisa-Elena Dumitrescu; Adrian Cosmin Roșca; Doina Drăgănescu; Carolina Negrei
Journal:  Nutrients       Date:  2022-06-26       Impact factor: 6.706

Review 3.  The Use of Probiotic Therapy in Metabolic and Neurological Diseases.

Authors:  Shirley H F Lee; Siti R Ahmad; Ya C Lim; Ihsan N Zulkipli
Journal:  Front Nutr       Date:  2022-05-03

Review 4.  Obesity and microbiota: an example of an intricate relationship.

Authors:  Sabrina Duranti; Chiara Ferrario; Douwe van Sinderen; Marco Ventura; Francesca Turroni
Journal:  Genes Nutr       Date:  2017-06-15       Impact factor: 5.523

5.  Metaproteomics reveals potential mechanisms by which dietary resistant starch supplementation attenuates chronic kidney disease progression in rats.

Authors:  Boris L Zybailov; Galina V Glazko; Yasir Rahmatallah; Dmitri S Andreyev; Taylor McElroy; Oleg Karaduta; Stephanie D Byrum; Lisa Orr; Alan J Tackett; Samuel G Mackintosh; Ricky D Edmondson; Dorothy A Kieffer; R J Martin; Sean H Adams; Nosratola D Vaziri; John M Arthur
Journal:  PLoS One       Date:  2019-01-30       Impact factor: 3.240

6.  The effects of the fiber source and xylanase supplementation on production, egg quality, digestibility, and intestinal morphology in the aged laying hen.

Authors:  A Abdollahi; A Karimi; A A Sadeghi; M R Bedford; M Ashengroph
Journal:  Poult Sci       Date:  2020-12-19       Impact factor: 3.352

7.  Benefits of resistant starch type 2 for patients with end-stage renal disease under maintenance hemodialysis: a systematic review and meta-analysis.

Authors:  Linpei Jia; Xingtong Dong; Xiaoxia Li; Rufu Jia; Hong-Liang Zhang
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

8.  Bifidobacterium lactis TY-S01 Prevents Loperamide-Induced Constipation by Modulating Gut Microbiota and Its Metabolites in Mice.

Authors:  Tian Tang; Jing Wang; Yuanyuan Jiang; Xu Zhu; Zhen Zhang; Yuying Wang; Xi Shu; Yadan Deng; Feng Zhang
Journal:  Front Nutr       Date:  2022-06-29

9.  Dietary fibre intake is low in paediatric chronic kidney disease patients but its impact on levels of gut-derived uraemic toxins remains uncertain.

Authors:  Ann Raes; Sunny Eloot; Amina El Amouri; Evelien Snauwaert; Aurélie Foulon; Charlotte Vande Moortel; Maria Van Dyck; Koen Van Hoeck; Nathalie Godefroid; Griet Glorieux; Wim Van Biesen; Johan Vande Walle
Journal:  Pediatr Nephrol       Date:  2021-01-02       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.